15 December 2014 : Special report
Efficacy of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Patients with/without EGFR-Mutation: Evidence Based on Recent Phase III Randomized Trials
DOI: 10.12659/MSM.892476
Med Sci Monit 2014; 20:2666-2676
HTML version available soon